MX2022002314A - Prediccion del riesgo de eventos cardiovasculares y sus usos. - Google Patents

Prediccion del riesgo de eventos cardiovasculares y sus usos.

Info

Publication number
MX2022002314A
MX2022002314A MX2022002314A MX2022002314A MX2022002314A MX 2022002314 A MX2022002314 A MX 2022002314A MX 2022002314 A MX2022002314 A MX 2022002314A MX 2022002314 A MX2022002314 A MX 2022002314A MX 2022002314 A MX2022002314 A MX 2022002314A
Authority
MX
Mexico
Prior art keywords
cardiovascular risk
risk event
event prediction
prediction
cardiovascular
Prior art date
Application number
MX2022002314A
Other languages
English (en)
Inventor
Michael Hinterberg
Gargi Datta
Original Assignee
Somalogic Operating Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somalogic Operating Co Inc filed Critical Somalogic Operating Co Inc
Publication of MX2022002314A publication Critical patent/MX2022002314A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

Se proporcionan biomarcadores, métodos, dispositivos, reactivos, sistemas y kits usados para evaluar a un individuo para la predicción del riesgo de desarrollar un evento cardiovascular (CV) primario o secundario durante un período de 4 años.
MX2022002314A 2019-09-03 2020-09-02 Prediccion del riesgo de eventos cardiovasculares y sus usos. MX2022002314A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962895383P 2019-09-03 2019-09-03
PCT/US2020/048981 WO2021046074A1 (en) 2019-09-03 2020-09-02 Cardiovascular risk event prediction and uses thereof

Publications (1)

Publication Number Publication Date
MX2022002314A true MX2022002314A (es) 2022-06-02

Family

ID=72521733

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022002314A MX2022002314A (es) 2019-09-03 2020-09-02 Prediccion del riesgo de eventos cardiovasculares y sus usos.

Country Status (11)

Country Link
US (1) US20220349904A1 (es)
EP (1) EP4025916A1 (es)
JP (1) JP2022546515A (es)
KR (1) KR20220057534A (es)
CN (1) CN114641692A (es)
AU (1) AU2020343243A1 (es)
BR (1) BR112022003666A2 (es)
CA (1) CA3151482A1 (es)
IL (1) IL290951A (es)
MX (1) MX2022002314A (es)
WO (1) WO2021046074A1 (es)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001577A (en) 1998-06-08 1999-12-14 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
US5763177A (en) 1990-06-11 1998-06-09 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
US5705337A (en) 1990-06-11 1998-01-06 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: chemi-SELEX
KR970002255B1 (ko) 1990-06-11 1997-02-26 넥스스타 파아마슈티컬드, 인크. 핵산 리간드
US5660985A (en) 1990-06-11 1997-08-26 Nexstar Pharmaceuticals, Inc. High affinity nucleic acid ligands containing modified nucleotides
US5580737A (en) 1990-06-11 1996-12-03 Nexstar Pharmaceuticals, Inc. High-affinity nucleic acid ligands that discriminate between theophylline and caffeine
US6458539B1 (en) 1993-09-17 2002-10-01 Somalogic, Inc. Photoselection of nucleic acid ligands
US6242246B1 (en) 1997-12-15 2001-06-05 Somalogic, Inc. Nucleic acid ligand diagnostic Biochip
EP2030025A2 (en) * 2006-06-07 2009-03-04 Tethys Bioscience, Inc. Markers associated with arteriovascular events and methods of use thereof
US7947447B2 (en) 2007-01-16 2011-05-24 Somalogic, Inc. Method for generating aptamers with improved off-rates
US7855054B2 (en) 2007-01-16 2010-12-21 Somalogic, Inc. Multiplexed analyses of test samples
EP2172566B2 (en) 2007-07-17 2022-05-18 Somalogic, Inc. Method for generating aptamers with improved off-rates
SG10201508656VA (en) 2010-07-09 2015-11-27 Somalogic Inc Lung cancer biomarkers and uses thereof
US20120077695A1 (en) 2010-09-27 2012-03-29 Somalogic, Inc. Mesothelioma Biomarkers and Uses Thereof

Also Published As

Publication number Publication date
BR112022003666A2 (pt) 2022-05-24
AU2020343243A1 (en) 2022-03-10
US20220349904A1 (en) 2022-11-03
WO2021046074A1 (en) 2021-03-11
CA3151482A1 (en) 2021-03-11
IL290951A (en) 2022-04-01
JP2022546515A (ja) 2022-11-04
EP4025916A1 (en) 2022-07-13
KR20220057534A (ko) 2022-05-09
CN114641692A (zh) 2022-06-17

Similar Documents

Publication Publication Date Title
EP4273775A3 (en) Method and apparatus for controlling appliance based on failure prediction
MX2021000540A (es) Metodo para transmision de datos en enlace lateral y dispositivo terminal.
CL2020001833A1 (es) Sistemas y métodos para priorizar informes de información de estado del canal.
MX2017014659A (es) Metodos y sistemas para la deteccion de variantes del numero de copias.
WO2016094182A3 (en) Network device predictive modeling
WO2020068836A3 (en) Task-based action generation
TN2020000055A1 (en) Methods and devices for performing an analytical measurement based on a color formation reaction
BR112017004967A2 (pt) método para retorno de csi dinâmico
EP4304116A3 (en) Methods and systems for determination of type of system information
MX2014003153A (es) Prediccion de riesgo de evento cardiovascular y usos del mismo.
BR112018069839A8 (pt) Estação-base, equipamento de usuário e método associado
BR112021019878A2 (pt) Método e aparelho para determinar informações de feixe e dispositivo de comunicação.
WO2019083351A3 (en) Method and system for disease prediction and control
BR112022026875A2 (pt) Habilitação de âncoras de posicionamento do equipamento de usuário (ue) para posicionamento de veículo-para-tudo (v2x), veículo-para-veículo (v2v) e veículo-para-pedestre (v2p)
CO2022002915A2 (es) Señalización dci con al menos un indicador de formato de ranura, sfi, campo e indicador de recurso de frecuencia
EP3525100A3 (en) Framework for developing and deploying applications
BR112018003775A2 (pt) método e aparelho de gerenciamento de recursos
EP3674242A3 (en) Enhancing elevator sensor operation for improved maintenance
EP4235179A3 (en) Detection, quantification and/or isolation of circulating tumor cells based on the expression of cd321 marker
PH12020551481A1 (en) Operation support system and operation support method for desulfurization apparatus
WO2020008392A3 (en) Predicting execution time of memory bandwidth intensive batch jobs
MX2021002056A (es) Metodo para depurar especies acidas de sulfuro.
MX2022002314A (es) Prediccion del riesgo de eventos cardiovasculares y sus usos.
WO2022086913A3 (en) Cardiovascular event risk prediction
MX2018011851A (es) Sistemas y metodos para ensayos de creatinina electroquimicos.